Azeliragon, a RAGE inhibitor, plus temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Final results from a dose-finding phase in the CAN-201 NDG trial.

azeliragon (TTP488) - Cantex Pharma

temozolomide - Generic mfg.

https://www.asco.org/abstracts-presentations/259634

Maria Martinez Garcia; Maria Castro-Henriques; Laia Cano; Stephen Marcus; Manuel Valiente; Juan Sepulveda; Estela Pineda; Maria Vaz-Salgado; Gonzalo Lendinez-Sanchez; Gabriel Velilla; Manuel Mazariegos-Rubi; Izaskun Valduvieco

Apr 21, 2026